Pioneering biotech out of Nobel laureate Jennifer Doudna's lab to cut nearly 50 jobs: Caribou Biosciences also ends trials ...

STAT's Adam Feuerstein puts all his “Biotech Doom Loop” panic-mongering aside, as he embraces luminescent moonbeams and downy ...

STAT reporters chat about pharma tariffs, the latest recovery in biotech stocks, and disappointing data from a Bristol Myers ...

Bay Area biotech company Tempest Therapeutics was once valued at more than $1 billion, but now it's running out of gas. Last week, the cancer researcher revealed plans to lay off all but five of its ...

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for ...

Pfizer (NYSE:PFE) is a global pharmaceutical giant that has long been a cornerstone of medical innovation and today boasts a $128 billion market cap. Renowned for its blockbuster drugs like Lipitor ...

Pittsburgh biotech firms see potential benefits from upcoming tariffs and reshoring efforts, despite uncertainties in NIH ...

Swiss biotech investor Xlife Sciences AG said on Wednesday its portfolio company Veraxa Biotech AG would list on U.S.

A vow by the agency’s new commissioner, Marty Makary, to support innovation might ease fears stoked by Health and Human ...

Biotech was starting to show signs of recovery after years of investor pullback—until new tariffs and economic uncertainty ...

ORIC Pharmaceuticals is advancing ORIC-114 for 1st-line EGFR/HER2 exon 20 NSCLC, with comprehensive data expected in the 2nd ...

As a stock-picking sector, investors can benefit from deep fundamental research on individual biotech companies ...